OrthoPediatrics Corp. (NASDAQ:KIDS) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of OrthoPediatrics Corp. (NASDAQ:KIDS) have earned an average recommendation of “Moderate Buy” from the eleven research firms that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have given a buy rating to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $24.4444.

KIDS has been the topic of several recent research reports. Canaccord Genuity Group set a $25.00 price target on shares of OrthoPediatrics in a research report on Friday, April 24th. BTIG Research reissued a “buy” rating and set a $24.00 price objective on shares of OrthoPediatrics in a report on Friday, May 1st. TD Cowen reissued a “buy” rating on shares of OrthoPediatrics in a research note on Monday, June 15th. Weiss Ratings restated a “sell (e+)” rating on shares of OrthoPediatrics in a report on Tuesday, April 21st. Finally, Truist Financial set a $17.00 target price on OrthoPediatrics in a research report on Friday, May 1st.

Institutional Trading of OrthoPediatrics

Several institutional investors have recently made changes to their positions in the company. Quantinno Capital Management LP purchased a new stake in shares of OrthoPediatrics in the first quarter valued at about $160,000. Waverly Advisors LLC purchased a new position in OrthoPediatrics during the first quarter worth about $184,000. Granahan Investment Management LLC grew its position in OrthoPediatrics by 35.1% in the 1st quarter. Granahan Investment Management LLC now owns 896,741 shares of the company’s stock worth $14,231,000 after purchasing an additional 232,760 shares in the last quarter. Sei Investments Co. grew its position in OrthoPediatrics by 31.1% in the 1st quarter. Sei Investments Co. now owns 82,081 shares of the company’s stock worth $1,303,000 after purchasing an additional 19,489 shares in the last quarter. Finally, Roubaix Capital LLC increased its stake in OrthoPediatrics by 23.8% in the 1st quarter. Roubaix Capital LLC now owns 290,047 shares of the company’s stock valued at $4,603,000 after buying an additional 55,724 shares during the last quarter. Institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Stock Down 2.8%

KIDS traded down $0.56 during trading on Tuesday, hitting $19.89. 73,970 shares of the company’s stock were exchanged, compared to its average volume of 158,985. OrthoPediatrics has a fifty-two week low of $14.42 and a fifty-two week high of $23.70. The stock has a market cap of $510.65 million, a P/E ratio of -11.84 and a beta of 0.99. The business’s 50 day moving average is $18.00 and its two-hundred day moving average is $17.54. The company has a quick ratio of 2.37, a current ratio of 5.21 and a debt-to-equity ratio of 0.29.

OrthoPediatrics (NASDAQ:KIDS) last issued its quarterly earnings data on Thursday, April 30th. The company reported ($0.42) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.46) by $0.04. The firm had revenue of $59.36 million during the quarter, compared to analysts’ expectations of $58.28 million. OrthoPediatrics had a negative net margin of 16.31% and a negative return on equity of 7.01%. As a group, equities analysts expect that OrthoPediatrics will post -1.13 earnings per share for the current fiscal year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.